These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29324225)

  • 1. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.
    King LB; Fusco ML; Flyak AI; Ilinykh PA; Huang K; Gunn B; Kirchdoerfer RN; Hastie KM; Sangha AK; Meiler J; Alter G; Bukreyev A; Crowe JE; Saphire EO
    Cell Host Microbe; 2018 Jan; 23(1):101-109.e4. PubMed ID: 29324225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.
    Ilinykh PA; Huang K; Santos RI; Gilchuk P; Gunn BM; Karim MM; Liang J; Fouch ME; Davidson E; Parekh DV; Kimble JB; Pietzsch CA; Meyer M; Kuzmina NA; Zeitlin L; Saphire EO; Alter G; Crowe JE; Bukreyev A
    Cell Host Microbe; 2020 Jun; 27(6):976-991.e11. PubMed ID: 32320678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macaque antibodies targeting Marburg virus glycoprotein induced by multivalent immunization.
    Janus BM; Wang R; Cleveland TE; Metcalf MC; Lemmer AC; van Dyk N; Jeong S; Astavans A; Class K; Fuerst TR; Ofek G
    J Virol; 2024 Jul; 98(7):e0015524. PubMed ID: 38832790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
    Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO
    mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses.
    Wec AZ; Nyakatura EK; Herbert AS; Howell KA; Holtsberg FW; Bakken RR; Mittler E; Christin JR; Shulenin S; Jangra RK; Bharrhan S; Kuehne AI; Bornholdt ZA; Flyak AI; Saphire EO; Crowe JE; Aman MJ; Dye JM; Lai JR; Chandran K
    Science; 2016 Oct; 354(6310):350-354. PubMed ID: 27608667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for Marburg virus neutralization by a cross-reactive human antibody.
    Hashiguchi T; Fusco ML; Bornholdt ZA; Lee JE; Flyak AI; Matsuoka R; Kohda D; Yanagi Y; Hammel M; Crowe JE; Saphire EO
    Cell; 2015 Feb; 160(5):904-912. PubMed ID: 25723165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein.
    Kajihara M; Marzi A; Nakayama E; Noda T; Kuroda M; Manzoor R; Matsuno K; Feldmann H; Yoshida R; Kawaoka Y; Takada A
    J Virol; 2012 Dec; 86(24):13467-74. PubMed ID: 23035224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk.
    King LB; West BR; Moyer CL; Gilchuk P; Flyak A; Ilinykh PA; Bombardi R; Hui S; Huang K; Bukreyev A; Crowe JE; Saphire EO
    Nat Commun; 2019 Apr; 10(1):1788. PubMed ID: 30996276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
    Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV-Vectored Expression of Marburg Virus-Neutralizing Antibody MR191 Provides Complete Protection From Challenge in a Guinea Pig Model.
    Rghei AD; Cao W; He S; Lopes JA; Zielinska N; Pei Y; Thompson B; Banadyga L; Wootton SK
    J Infect Dis; 2023 Nov; 228(Suppl 7):S682-S690. PubMed ID: 37638865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions.
    Bozhanova NG; Sangha AK; Sevy AM; Gilchuk P; Huang K; Nargi RS; Reidy JX; Trivette A; Carnahan RH; Bukreyev A; Crowe JE; Meiler J
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31142-31148. PubMed ID: 33229516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of human antibody-mediated neutralization of Marburg virus.
    Flyak AI; Ilinykh PA; Murin CD; Garron T; Shen X; Fusco ML; Hashiguchi T; Bornholdt ZA; Slaughter JC; Sapparapu G; Klages C; Ksiazek TG; Ward AB; Saphire EO; Bukreyev A; Crowe JE
    Cell; 2015 Feb; 160(5):893-903. PubMed ID: 25723164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses.
    Brouillette RB; Phillips EK; Ayithan N; Maury W
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure.
    Kajihara M; Nakayama E; Marzi A; Igarashi M; Feldmann H; Takada A
    J Gen Virol; 2013 Apr; 94(Pt 4):876-883. PubMed ID: 23288419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
    Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor.
    Kuhn JH; Radoshitzky SR; Guth AC; Warfield KL; Li W; Vincent MJ; Towner JS; Nichol ST; Bavari S; Choe H; Aman MJ; Farzan M
    J Biol Chem; 2006 Jun; 281(23):15951-8. PubMed ID: 16595665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design.
    Khurana S; Grubbs G; Ravichandran S; Cluff E; Kim J; Kuehne AI; Zak S; Dye JM; Lutwama JJ; Herbert AS
    Nat Commun; 2024 Sep; 15(1):8133. PubMed ID: 39285186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP.
    Reynard O; Volchkov VE
    J Infect Dis; 2015 Oct; 212 Suppl 2():S372-8. PubMed ID: 26232760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
    Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.